| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NeuroSense Therapeutics Ltd. | Chief Medical Officer | Ordinary Shares | 428,011 | $376,649 | $0.8800 | 18 Mar 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NRSN | NeuroSense Therapeutics Ltd. | 18 Mar 2026 | 0 | $0 | 3 | Chief Medical Officer | 18 Mar 2026, 15:36 |